Showing results (81-90 of 171) with videos related to
Sort By:
Pageof 18
Clinical and Experimental Immunology|February 1, 1981
Generation of suppressor cells by aggregated human globulinJ P Antel, M E Medof, J J Oger, et al.The Journal of Biological Chemistry|May 15, 1993
A candidate mammalian glycoinositol phospholipid precursor containing three phosphoethanolaminesE Ueda, D Sevlever, G M Prince, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 1, 1990
Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavageE I Walter, W L Roberts, T L Rosenberry, et al.The Journal of Biological Chemistry|January 15, 1992
Effect of glycoinositolphospholipid anchor lipid groups on functional properties of decay-accelerating factor protein in cellsE I Walter, W D Ratnoff, K E Long, et al.Proceedings of the National Academy of Sciences of the United States of America|August 5, 1997
Resistance to apoptosis caused by PIG-A gene mutations in paroxysmal nocturnal hemoglobinuriaR A Brodsky, M S Vala, J P Barber, et al.Proceedings of the National Academy of Sciences of the United States of America|June 1, 1989
Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factorM M Lederman, S F Purvis, E I Walter, et al.The Journal of Clinical Investigation|July 1, 1987
Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytesM E Medof, A Gottlieb, T Kinoshita, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Generation of recombinant fragments of CD11b expressing the functional beta-glucan-binding lectin site of CR3 (CD11b/CD18)Y Xia, G D RossClinical and Experimental Immunology|May 1, 1993
CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functionsG D Ross, V VĕtvickaClinical and Experimental Immunology|February 24, 2001
Tears contain the complement regulator CD59 as well as decay-accelerating factor (DAF)E Cocuzzi, L B Szczotka, W G Brodbeck, et al.Pageof 18